50 RICHMOND STREET EAST, SUITE 300
TORONTO
Ontario
Canada,
M5C 1M1
Phone: +1 (416) 813-0303
Fax: +1 (416) 596-9840
|
Company SummaryBacTech owns commercially-proven bacterial oxidation and bioleaching technologies that liberate precious metals from difficult-to-treat sulphide ores and concentrates. BacTech is expanding the use of its patented BACOX bioleaching technology to the processing of toxic, arsenic-laden mine tailings. Company NewsMonday, November 16, 2009 Gold Anomaly announced that the company will commence a Bankable Feasibility Study on the Fergusson Island JV project located in Papua New Guinea. In addition, the company will be entering into an Agreement revising the original arrangement with BacTech and Yamana such that Gold Anomaly will now be acquiring 100% of the project. As part of the restructured transaction, BacTech will provide its specialist metallurgical services to undertake the bacterial leach component of a Bankable Feasibility Study with Gold Anomaly to undertake all other evaluations. Yamana will become a shareholder in Gold Anomaly. News ReleasesTuesday, November 17, 2009 Monday, November 16, 2009 Tuesday, October 06, 2009 Friday, September 25, 2009 Map Legend: Producer Past Producer  Development  Exploration |
Advanced or Above
